Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca Covid-19 vaccine, Department of Biotechnology (DBT) Secretary Renu Swarup said on … Read More
NEW DELHI: Chief minister Ashok Gehlot had “unconstitutionally” merged six MLAs of the Bahujan Samaj Party (BSP) with the Congress in Rajasthan, he did the same in his earlier tenure … Read More
Three months after passing an amendment to sanction a new political map that identifies Kalapani in Uttarakhand as its own, Nepal has inscribed the changes in its academic curriculum and currency. A book for higher secondary students includes the disputed Kalapani as Nepal’s territory and the Central Bank has been allowed to mint one and two-rupee coins with the new map.
India’s Covid-19 case tally crosses 52-lakh mark with a spike of 96,424 new cases & 1,174 deaths in last 24 hours. The total case tally stands at 52,14,678 including 10,17,754 active cases, 41,12,552 cured/discharged/migrated & 84,372 deaths, said the health ministry. Globally, over 30 million people have been infected with the coronavirus. Stay with TOI for live updates.
US drug developer Novavax Inc said on Tuesday it was doubling its potential Covid-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%. In August, Novavax signed a deal with Serum Institute to produce a minimum of one billion doses of its vaccine candidate.